Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Lan Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Sch…. Hauptthemen laut MEDLINE: Anti-Infective Agents, Communicable Diseases, Biological Products. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) emerges as a severe crisis to public health and requires global action. The occurrence of bacterial pathogens with multi‐drug resistance appeals to exploring alternative therapeutic strategies. Antivirulence treatment has been a positive substitute in seeking to circumvent AMR, which aims to target virulence factors directly to combat bacterial infections. Accumulated evidence suggests that plant‐derived natural products, which have been utilized to treat infectious diseases for centuries, can be abundant sources for screening potential virulence‐arresting drugs (VADs) to develop advanced therapeutics for infectious diseases. This review sums up some virulence factors and their actions in various species of bacteria, as well as recent advances pertaining to plant‐derived natural products as VAD candidates. Furthermore, we also discuss natural VAD‐related clinical trials and patents, the perspective of VAD‐based advanced therapeutics for infectious diseases and critical challenges hampering clinical use of VADs, and genomics‐guided identification for VAD therapeutic. These newly discovered natural VADs will be encouraging and optimistic candidates that may sustainably combat AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, Sichuan, P.R. China.
- Faculty of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, P.R. China.
- Safety Evaluation Center, Sichuan Institute for Drug Control (Sichuan Testing Center of Medical Devices), Chengdu, Sichuan, P.R. China.
- Department of Hepatobiliary Surgery, Langzhong People's Hospital, Langzhong, Sichuan, P.R. China.
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
- Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China.
ORCID-Profile: Mingxing Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lu, L., Wang, J., Wang, C., Zhu, J., Wang, H., Liao, L., Zhao, Y., Wang, X., Yang, C., He, Z., & Li, M. (2024). Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use. Phytotherapy Research. https://doi.org/10.1002/ptr.8072
Vancouver
Lu L, Wang J, Wang C, Zhu J, Wang H, Liao L, et al. Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use. Phytotherapy Research. 2024. doi:10.1002/ptr.8072
BibTeX
@article{Lu2024,
author = {Lu, Lan and Wang, Jingya and Wang, Chongrui and Zhu, Jie and Wang, Hongping and Liao, Li and Zhao, Yuting and Wang, Xiaobo and Yang, Chen and He, Zhengyou and Li, Mingxing},
title = {Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8072}
}
EUVIMED